UIPS awarded conference grant under GJCLSG for year 2023-24

Chandigarh, February 16, 2024: University Institute of Pharmaceutical Sciences (UIPS) was awarded conference grant under Golden Jubilee Conference and Lecture Series Grant (GJCLSG) for the year 2023-24 by Shastri Indo Canada Institute (SICI), New Delhi. UIPS organized thebilateral one day symposium between India and Canada on theme “EMERGING NEUROLOGICAL DISEASES AND POSSIBLE THERAPEUTICS IN POST - COVID ERA” today i.e. Friday, 16th February 2024, 9.00 a.m. onwards. The invited speakers were Professor Dr. ShreejoyTripathy, Independent Scientist fromThe Centre for Addiction and Mental Health and Dept. of Psychiatry, Physiology, University of Toronto and Dr. MahendraBishnoi, NABI, Mohali, and Professor Shyam S Sharma, NIPER SAS Nagar

Professor Anil Kumar, Chairperson, UIPS welcomed the audience and briefed them about the achievements of UIPS and expressed his heartfelt gratitude to SICI for the funding and Professor Dr. ShreejoyTripathy, Professor Shyam S Sharmaand Dr. MahendraBishnoi, accomplished neurosciencescientist for concedingto the request of the Institute to be our speakers of this one day symposium. 

DrPrachiKaul, Director, SICIin her opening remarks gave an overview of SICI and its active role in setting up collaborations across India and Canada. DrKaul also talked about all possible opportunities that can be availed at SICI for research grants and fellowships. 

Professor Kanwaljit Chopra, Convener of the symposium gave brief overview of the programand introduced the speakers to the audience highlighting their vast repertoire of achievements

The eminent speaker deliberated upon  howneurological disorders are the leading cause of disability and the second leading cause of death worldwide.  The most complex and debilitating neurological diseases affect humanity. Brain disorders like Alzheimer’s disease, Parkinson disease, Huntington’s disease, traumatic brain injury and stroke affect millions people worldwide each year and have limited effective treatments. Today’s symposium enlightened all the participants and neuroscience researchers on potential therapies for chronic neurological disorders, cellular and molecular mechanisms of virus induced neurodegeneration, modulation of gut brain axis and will provide deeper insights on emerging role of AI and technological advancement in unraveling brain dysfunction, targeting of underlying genetic, molecular & physiological deficits in patients and for development of novel neurotherapeutic strategies

The speakers were honored with certificate of felicitation after their respective talks.

The participants presented their research through oral and poster presentations and winners were felicitated with prize trophies and certificate in under undergraduate, postgraduate and phd/postdoc research categories.